Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein
- 5 March 2005
- Vol. 334 (2), 160-165
- https://doi.org/10.1016/j.virol.2005.01.042
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Immunization with Modified Vaccinia Virus Ankara-Based Recombinant Vaccine against Severe Acute Respiratory Syndrome Is Associated with Enhanced Hepatitis in FerretsJournal of Virology, 2004
- Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccineBiochemical and Biophysical Research Communications, 2004
- Protective Immunity to Vaccinia Virus Induced by Vaccination with Multiple Recombinant Outer Membrane Proteins of Intracellular and Extracellular VirionsJournal of Virology, 2004
- Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferretsThe Lancet, 2004
- Mucosal immunisation of African green monkeys ( Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARSThe Lancet, 2004
- Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes miceProceedings of the National Academy of Sciences, 2004
- Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of MiceJournal of Virology, 2004
- A DNA vaccine induces SARS coronavirus neutralization and protective immunity in miceNature, 2004
- The SARS-CoV S glycoprotein: expression and functional characterizationBiochemical and Biophysical Research Communications, 2003
- Newly discovered coronavirus as the primary cause of severe acute respiratory syndromeThe Lancet, 2003